Neuroscience Focus ERG specializes in early and late stage neuroscience drug development with a robust in-patient and out-patient trial network, indicating strong potential for CRO partnerships, site access, and patient recruitment in neuro-related programs.

Expanded Site Network Ownership of 21 clinical sites plus affiliations across multiple regions creates a broad footprint for multi-site studies, enabling scalable patient enrollment and regional trial coverage for sponsors seeking diverse geographic reach.

Data and Access A large patient database spanning mental illness, neurological disorders, sleep disorders, pain, diabetes and more, plus access to healthy volunteers, suggests opportunities for fast recruitment, richer data capture, and feasibility support for early phase trials.

Central Infrastructure Centralized infrastructure in New Jersey paired with specialized services such as ECG, PSG, EEG, qEEG, actigraphy, and medical writing positions ERG as a convenient, end-to-end solution for complex CNS and translational studies.

Consulting Upsell Beyond site execution, ERG offers design, feasibility, budgeting, and investigator access services, presenting opportunities for partnerships on study design, protocol optimization, and advisory board engagement with pharmaceutical and CRO clients.